Litepaper

What ANSES Actually Concluded About Artificial-Snow Additives

ANSES rated artificial-snow risk 'null to negligible' and flagged source-water microbiology, not the additive. The primary document, read straight.

France's health and environment agency, ANSES (through its predecessor Afsset), assessed artificial snow and its additives in 2008 and rated the health risk as "null to negligible" for the general public and "negligible to low" for exposed workers. The concern it actually flagged was the microbiology of the source water, not the snowmaking additive. The finding is routinely misquoted.

If you search for what regulators concluded about snowmaking additives, you get a fog of secondhand claims — that additives were "found dangerous," that France "banned" them on safety grounds. The primary document says almost the opposite. This is a plain-language walkthrough of what ANSES/Afsset actually assessed and concluded, and why the distinction matters for any operator or investor doing diligence.

What did ANSES actually conclude about snowmaking additives?

ANSES's predecessor Afsset published a risk assessment (reference 2005-ET-0007) that rated the sanitary risk from artificial snow as "null to negligible" for the general population and "negligible to weak" for occupationally exposed workers. It did not find additives dangerous. Where it raised a flag, it was about the microbiological quality of the water used to make snow — a water-source issue, not an additive issue.

That is the load-bearing sentence, and it is worth stating precisely because so much secondary coverage gets it wrong. The agency's published opinion and report (French original here) assessed both the physical practice of making artificial snow and the additives used in it, and reached a reassuring conclusion on the additive question while pointing regulators toward source-water hygiene instead.

Did ANSES ban Snomax or artificial-snow additives?

No. ANSES is a risk-assessment agency; it does not issue bans. And its assessment did not recommend one for additives on safety grounds. The end of Snomax use in France in 2005 came through an industry-wide suspension of cryogenic additives by the resort operators' association — a commercial and precautionary decision, not a statutory or health-authority prohibition.

This is a frequent and consequential confusion, so the sequence matters:

  • 2005 — French resorts, through Domaines Skiables de France, suspended the use of cryogenic snowmaking additives. This was an industry moratorium. No French government decree or health-authority ban was issued.
  • 2008 — Afsset (later ANSES) published its risk assessment, which rated the additive risk as null-to-negligible and directed concern to source-water microbiology.

So the timeline is the opposite of the popular story: the suspension came first, as a precaution, and the formal risk assessment that followed did not support the idea that additives were hazardous. We cover the broader regulatory picture in is Snomax banned in Europe.

What was ANSES actually worried about, if not the additive?

The genuine concern was the microbiological quality of the water drawn to make snow — reservoirs, rivers, and reclaimed water can carry bacteria and other contaminants regardless of whether any additive is present. The additive was assessed and largely cleared; the water source was where the agency directed attention.

This distinction is important for two reasons. First, it means the historical caution around artificial snow was about water hygiene, a problem every resort manages independently of chemistry. Second, it reframes what a well-characterised additive has to prove: not that it is harmless in isolation (the assessment already leans that way for the class studied), but that it does not add a new burden to water that must meet its own standards.

The peer-reviewed literature reached compatible conclusions. Joly et al. 2010 in Science of the Total Environment examined artificial-snow additive risk and found the environmental exposure limited. The pattern across the primary sources is consistent: measured, low-to-negligible risk, with the residual questions sitting on water quality rather than the additive molecule.

How does the ANSES finding fit the wider European regulatory map?

The ANSES assessment sits inside a patchwork of national rules, and it is the analytical anchor for the markets that permit additives. France discontinued cryogenic additives by industry suspension; Austria and Bavaria prohibit all additives by statute; Italy, Switzerland, and non-Alpine geographies permit them. The risk science and the legal status are two separate axes, and conflating them is the root of most errors.

It helps to hold the two axes apart explicitly:

  • The science axis — what the risk assessments found. Here ANSES/Afsset and the peer-reviewed work converge on low-to-negligible risk from the additive, with source-water microbiology as the residual concern.
  • The legal axis — what each jurisdiction permits. This tracks national water law and precaution, not the risk science. Austria and Bavaria's prohibition of all foreign substances in snowmaking water is a legal rule about water purity, applied regardless of any specific product's risk profile.

The consequence is that a low-risk finding does not open a closed market, and a closed market does not imply a high-risk product. The addressable regulated markets for any additive — SL6733 included — are France, Italy, Switzerland, and non-Alpine geographies, a map driven by law rather than by the ANSES risk verdict. The full jurisdictional detail is in the EU snowmaking additive regulations guide. Water abstraction and additive rules also interact with member-state permitting under the Water Framework Directive, so operators face a compliance question that is regulatory before it is scientific.

How does this apply to a modern polymer additive like SL6733?

The ANSES finding sets a useful baseline: the historical regulatory concern was source-water microbiology, not additive chemistry. A synthetic polymer that is biology-free sidesteps the microbiological question entirely, and stands or falls instead on its residual-monomer specification and environmental fate — parameters that are well-defined and measurable.

Here is how the different additive types map onto what ANSES was and was not worried about:

| Additive type | Microbiological concern | Chemical concern | |---|---|---| | Biological nucleant (Snomax) | Assessed; risk rated null-to-negligible, but biological classification drives precaution | Low | | Surfactant (Drift) | Minimal | Surfactant load | | Polymer (SL6733) | None — biology-free | Residual free acrylamide monomer (≤0.05% spec) | | Source water (all cases) | The actual flagged issue | Varies by catchment |

For a polyacrylamide-based polymer, the governing safety number is residual free acrylamide monomer, held to a ≤0.05% ceiling that matches the USDA NRCS anionic-PAM standard and sits well inside the EU Drinking Water Directive's 0.1 µg/L acrylamide limit at a snowmaking dose of a few ppm. It is worth stating plainly that polyacrylamide is not readily biodegradable, though it is non-bioaccumulative and low in aquatic toxicity — the honest version, not the marketing version. The chemistry detail is in what SL6733 is.

Why is getting this right a credibility issue?

Because the whole category is small enough that a single misquoted regulatory claim propagates. Investors and operators doing diligence will find the primary ANSES document in minutes; anyone whose marketing says "additives were found dangerous" or "France banned them on safety grounds" is immediately contradicted by the source. Accuracy here is a trust signal.

The reflex in a competitive niche is to reach for the strongest-sounding claim — "banned," "found unsafe," "prohibited across Europe." Every one of those is wrong, and each is easy to check. The durable position is the accurate one: additives were assessed as low-risk, the flagged concern was water microbiology, and the French exit was an industry suspension rather than a government ban. Stating that correctly is not a concession — it is what separates a credible technical source from a marketing page. We hold to it as a matter of policy across the Journal.

Key takeaways

  • ANSES/Afsset (2008, ref 2005-ET-0007) rated artificial-snow risk as "null to negligible" (public) and "negligible to low" (workers) — it did not find additives dangerous.
  • The concern the agency actually flagged was the microbiological quality of source water, not the additive.
  • ANSES does not issue bans; the end of Snomax in France (2005) was an industry-wide suspension of cryogenic additives, not a statutory prohibition. The suspension preceded the assessment.
  • Peer-reviewed work (Joly et al. 2010) reached compatible low-risk conclusions.
  • A biology-free polymer sidesteps the microbiological question and is governed instead by its residual-monomer spec (≤0.05%); polyacrylamide is not readily biodegradable but is low-toxicity at ppm doses.

The bottom line

The ANSES record is one of the clearest examples of how a regulatory finding gets flattened into a slogan. Read the source and the picture is measured: low risk from the additive, real questions about water hygiene, and a French exit driven by industry caution rather than a safety verdict. For a company building on synthetic polymer chemistry, that record is not an obstacle to explain away — it is the accurate foundation the category should have been built on.

If you are evaluating the regulatory standing of a snowmaking additive for your operation, the EU regulations guide and the Snomax alternatives comparison go deeper. To discuss a pilot, get in touch.

Disclaimer: SL6733 is pre-commercial; EU lab pilots are targeted for the 2026/27 season. Regulatory status statements reflect published sources as of July 2026 and are not legal advice. DeepSnow Srl (Italy) is in formation; SnowLabs Limited (Ireland) is the operating entity.